463 related articles for article (PubMed ID: 1653278)
1. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages.
Hubbard RC; Fells G; Gadek J; Pacholok S; Humes J; Crystal RG
J Clin Invest; 1991 Sep; 88(3):891-7. PubMed ID: 1653278
[TBL] [Abstract][Full Text] [Related]
2. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.
Hubbard RC; Ogushi F; Fells GA; Cantin AM; Jallat S; Courtney M; Crystal RG
J Clin Invest; 1987 Nov; 80(5):1289-95. PubMed ID: 2824559
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase.
Ogushi F; Hubbard RC; Vogelmeier C; Fells GA; Crystal RG
J Clin Invest; 1991 Mar; 87(3):1060-5. PubMed ID: 1999486
[TBL] [Abstract][Full Text] [Related]
4. Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.
Ogushi F; Fells GA; Hubbard RC; Straus SD; Crystal RG
J Clin Invest; 1987 Nov; 80(5):1366-74. PubMed ID: 3500183
[TBL] [Abstract][Full Text] [Related]
5. Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency.
Hubbard RC; McElvaney NG; Sellers SE; Healy JT; Czerski DB; Crystal RG
J Clin Invest; 1989 Oct; 84(4):1349-54. PubMed ID: 2794066
[TBL] [Abstract][Full Text] [Related]
6. Augmentation therapy of alpha 1-antitrypsin deficiency.
Hubbard RC; Crystal RG
Eur Respir J Suppl; 1990 Mar; 9():44s-52s. PubMed ID: 2340051
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
Abboud RT; Vimalanathan S
Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
[TBL] [Abstract][Full Text] [Related]
8. Pallid mice with genetic emphysema. Neutrophil elastase burden and elastin loss occur without alteration in the bronchoalveolar lavage cell population.
de Santi MM; Martorana PA; Cavarra E; Lungarella G
Lab Invest; 1995 Jul; 73(1):40-7. PubMed ID: 7603039
[TBL] [Abstract][Full Text] [Related]
9. Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.
Martin TR; Raugi G; Merritt TL; Henderson WR
J Clin Invest; 1987 Oct; 80(4):1114-24. PubMed ID: 2821074
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the S-type of alpha-1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase.
Ogushi F; Hubbard RC; Fells GA; Casolaro MA; Curiel DT; Brantly ML; Crystal RG
Am Rev Respir Dis; 1988 Feb; 137(2):364-70. PubMed ID: 3257660
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil recruitment into the lungs is associated with increased lung elastase burden, decreased lung elastin, and emphysema in alpha 1 proteinase inhibitor-deficient mice.
Cavarra E; Martorana PA; Gambelli F; de Santi M; van Even P; Lungarella G
Lab Invest; 1996 Aug; 75(2):273-80. PubMed ID: 8765327
[TBL] [Abstract][Full Text] [Related]
12. Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals.
Mornex JF; Chytil-Weir A; Martinet Y; Courtney M; LeCocq JP; Crystal RG
J Clin Invest; 1986 Jun; 77(6):1952-61. PubMed ID: 3486887
[TBL] [Abstract][Full Text] [Related]
13. Elastase inhibitors of the respiratory tract.
Stockley RA; Morrison HM
Eur Respir J Suppl; 1990 Mar; 9():9s-15s. PubMed ID: 2340054
[TBL] [Abstract][Full Text] [Related]
14. Modulation of alveolar macrophage leukotriene B4 released by complement component C5.
Robbins RA; Gossman GL; Allington LA; Kendall TJ; Stull TW; Rennard SI
J Lab Clin Med; 1990 Apr; 115(4):497-503. PubMed ID: 2157785
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil chemotactic activity produced by normal and activated human bronchoalveolar lavage cells.
Sibille Y; Naegel GP; Merrill WW; Young KR; Care SB; Reynolds HY
J Lab Clin Med; 1987 Nov; 110(5):624-33. PubMed ID: 2822825
[TBL] [Abstract][Full Text] [Related]
16. The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.
O'Dwyer CA; O'Brien ME; Wormald MR; White MM; Banville N; Hurley K; McCarthy C; McElvaney NG; Reeves EP
J Immunol; 2015 Oct; 195(8):3628-41. PubMed ID: 26371243
[TBL] [Abstract][Full Text] [Related]
17. The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency.
Martorana PA; Brand T; Gardi C; van Even P; de Santi MM; Calzoni P; Marcolongo P; Lungarella G
Lab Invest; 1993 Feb; 68(2):233-41. PubMed ID: 8441253
[TBL] [Abstract][Full Text] [Related]
18. Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency.
Hubbard RC; Sellers S; Czerski D; Stephens L; Crystal RG
JAMA; 1988 Sep; 260(9):1259-64. PubMed ID: 3261353
[TBL] [Abstract][Full Text] [Related]
19. Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis.
Nuijens JH; Abbink JJ; Wachtfogel YT; Colman RW; Eerenberg AJ; Dors D; Kamp AJ; Strack van Schijndel RJ; Thijs LG; Hack CE
J Lab Clin Med; 1992 Feb; 119(2):159-68. PubMed ID: 1740629
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis.
Ozaki T; Hayashi H; Tani K; Ogushi F; Yasuoka S; Ogura T
Am Rev Respir Dis; 1992 Jan; 145(1):85-91. PubMed ID: 1309969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
